(NASDAQ: COO) Cooper Companies's forecast annual revenue growth rate of 3.55% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.9%.
Cooper Companies's revenue in 2025 is $4,045,700,000.On average, 6 Wall Street analysts forecast COO's revenue for 2025 to be $814,546,789,732, with the lowest COO revenue forecast at $812,273,608,530, and the highest COO revenue forecast at $818,158,352,591. On average, 6 Wall Street analysts forecast COO's revenue for 2026 to be $861,725,935,966, with the lowest COO revenue forecast at $848,727,212,284, and the highest COO revenue forecast at $872,592,235,161.
In 2027, COO is forecast to generate $911,195,758,587 in revenue, with the lowest revenue forecast at $895,799,200,509 and the highest revenue forecast at $931,300,509,532.